t(3;21)(q26;q22) in myeloid leukemia: An aggressive syndrome of blast transformation associated with hydroxyurea or antimetabolite therapy

C. Cameron Yin, Jorge Cortes, Bedia Barkoh, Kimberly Hayes, Hagop Kantarjian, Dan Jones

Research output: Contribution to journalArticlepeer-review

39 Scopus citations

Fingerprint Dive into the research topics of 't(3;21)(q26;q22) in myeloid leukemia: An aggressive syndrome of blast transformation associated with hydroxyurea or antimetabolite therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences